Literature DB >> 1792420

Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis.

H Hamm1, B Pfalzer, H Fabel.   

Abstract

A chyliform effusion is an uncommon high lipid pleural effusion that does not result from a leakage of the thoracic duct. Characteristically, it emerges from chronic pleurisy and contains high levels of cholesterol. The origin of this cholesterol is unknown, but it is often attributed to the degeneration of red and white blood cells. In this study we have carried out detailed lipoprotein analyses in a chyliform effusion, a chronic tuberculous effusion and three inflammatory effusions of recent onset, in an attempt to elucidate the process of cholesterol accumulation and possible lipoprotein alterations. Mean cholesterol was 92 mg/dl in the inflammatory exudates and 1,237 mg/dl in the chyliform effusion. In inflammatory effusions of recent onset most cholesterol was bound to low density lipoprotein (LDL) with corresponding apoprotein B levels. The chronic tuberculous exudate showed a shift of cholesterol binding towards high density lipoprotein (HDL). In the chyliform effusion most cholesterol was found in the HDL region. Our results suggest that in acute inflammation, the pleural barrier opens to plasma LDL. We hypothesize that in chronicity this cholesterol becomes trapped in the pleural space and undergoes a change in lipoprotein binding characteristics. In a chyliform effusion, cholesterol further accumulates and builds complexes containing triglycerides and proteins. In clinical routine, total cholesterol values above 200 mg/dl strongly suggest a chyliform effusion. Since triglyceride values may be as high as in chylous effusions (greater than 110 mg/dl), the diagnostic routine in all suspected high lipid effusions should involve cholesterol and triglyceride measurements.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1792420     DOI: 10.1159/000195948

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  7 in total

1.  Usefulness of triglyceride levels in pleural fluid.

Authors:  Luis Valdés; Maria Esther San José; Antonio Pose; Juan Carlos Estévez; Francisco J González-Barcala; José M Alvarez-Dobaño; Richard W Light
Journal:  Lung       Date:  2010-10-05       Impact factor: 2.584

2.  Characteristics of patients with pseudochylothorax-a systematic review.

Authors:  Adriana Lama; Lucía Ferreiro; María E Toubes; Antonio Golpe; Francisco Gude; José M Álvarez-Dobaño; Francisco J González-Barcala; Esther San José; Nuria Rodríguez-Núñez; Carlos Rábade; Carlota Rodríguez-García; Luis Valdés
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

3.  Pleural effusions in children undergoing cardiac surgery.

Authors:  Sachin Talwar; Sandeep Agarwala; Chander Mohan Mittal; Shiv Kumar Choudhary; Balram Airan
Journal:  Ann Pediatr Cardiol       Date:  2010-01

4.  An unusual case of pseudochylothorax.

Authors:  M Padma Priya; S Dharmic; Aparajeet Kar; V Suryanarayana
Journal:  J Pharm Bioallied Sci       Date:  2015-04

Review 5.  Pleural effusion: diagnosis, treatment, and management.

Authors:  Vinaya S Karkhanis; Jyotsna M Joshi
Journal:  Open Access Emerg Med       Date:  2012-06-22

6.  Lipoprotein profile of pleural and peritoneal transudates in dogs and cats.

Authors:  Flavio H Alonso; Erica Behling-Kelly; Dori L Borjesson
Journal:  J Vet Intern Med       Date:  2022-02-15       Impact factor: 3.333

7.  Extravasation of TPN following central venous catheter migration.

Authors:  SungMin Hong; Sung Hyun Kim; Hyun-Kyung Lee; Young-Min Lee; Mi-Yeong Kim; Hongyeul Lee; Ho-Young Lee
Journal:  Respir Med Case Rep       Date:  2022-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.